Finnish clinical trials to study enterovirus vaccine to see if it may help prevent type 1 diabetes
Categories: For Potential Participants, [Diabetes, Clinical Trials, Enteroviruses, Vaccine]
Enteroviruses are the most common types of viruses and cause a range of symptoms from the flu to heart inflammation. Enteroviruses have been associated with type 1 diabetes for some time. In one recent study, researchers found an association between a specific enterovirus, called coxsackievirus B1, and an increased likelihood of developing type 1 diabetes in children.
Now, one clinical trial in Finland is planning to look at a possible vaccine based on the enterovirus research. The clinical trial, which is expected to begin this year, will test how safe the vaccine is in adults. In the second phase, the vaccine will be studied in children, and the aim is to see how safe it is and how well it works against enteroviruses. In the third phase, the aim is to see if the vaccine could be used to prevent type 1 diabetes.
Type 1 diabetes is an autoimmune disorder usually diagnosed in children, teens, and young adults. The disease is believed to be caused by environmental factors, the immune system, and genetics.
Interested in learning more about type 1 diabetes research? Register on ClinicalResearch.com to receive news about diabetes and related IQVIA clinical trials. Check ClinicalResearch.com often for updates and news on a variety of disease areas and to find out more about some of the latest clinical research trials.